GLP-1 Drugs: A Weight Loss Breakthrough
Discover the fascinating history behind the development of GLP-1 drugs like ozempic and wegovy, which were originally intended for type two diabetes treatment but have now emerged as effective weight loss solutions. Delve into the complex world of pharmaceuticals and explore the untold story of Novo Nordisk, a 100-year-old company with a rich history. Learn how GLP-1 drugs have the potential to revolutionize food intake reduction and why this breakthrough is capturing public attention.In this clip
From this podcast
Acquired
Novo Nordisk (Ozempic)
Related Questions